LOS ANGELES, May 17, 2016 /PRNewswire/
-- StockNewsNow.com, The Official MicroCap News Source™, today
published an SNNLive Video Interview with Peter R. Culpepper, Interim CEO and COO of
Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT), specializes in
developing oncology and dermatology therapies, according to the
company's website (see here: www.ProvectusBio.com). The video
interview was recorded on Wednesday, May
4th, 2016, at the Growth Capital Expo MicroCap
Investor Conference in Las Vegas,
NV.
Click the following link to watch the SNNLive Video Interview on
StockNewsNow.com:
Update with Provectus Biopharmaceuticals, Inc. - Discusses
Clinical Developments for PV-10, Immunotherapy, Goals and
Milestones
You can follow Stock News Now on FACEBOOK, TWITTER, LINKEDIN,
YOUTUBE, and STOCKTWITS
Please review important disclosures on our website at:
http://stocknewsnow.com/legal.php#disclaimer
About Provectus Biopharmaceuticals, Inc.
Provectus Biopharmaceuticals, Inc. specializes in developing
oncology and dermatology therapies. PV-10, its novel
investigational drug for cancer, is designed for injection into
solid tumors (intralesional administration), thereby reducing
potential for systemic side effects. Its oncology focus is on
melanoma, breast cancer and cancers of the liver. The Company has
received orphan drug designations from the FDA for its melanoma and
hepatocellular carcinoma indications. PH-10, its topical
investigational drug for dermatology, is undergoing clinical
testing for psoriasis and atopic dermatitis. Provectus has
completed phase 2 trials of PV-10 as a therapy for metastatic
melanoma, and of PH-10 as a topical treatment for atopic dermatitis
and psoriasis. Information about these and the Company's other
clinical trials, including its current phase 3 study in melanoma,
can be found at the NIH registry, www.clinicaltrials.gov.
Description of the company and for additional information about
Provectus, please visit the Company's website
at www.ProvectusBio.com, or contact Porter, LeVay & Rose,
Inc.
About StockNewsNow.com
StockNewsNow.com is a microcap financial news portal that
features news and insights from the microcap and emerging growth
financial community. StockNewsNow.com is a multimedia destination
hub for information about microcap and emerging growth public and
private companies, market events, news, bulletins, stock quotes,
expert commentary and company profiles that feature SNN-produced
video like SNNLive CEO video interviews, as well as their latest
news and headlines. Users can engage directly and share the
information provided through social media.
Follow the companies YOU want to know more about; read and watch
content from YOUR favorite microcap, emerging growth financial
experts; register to attend financial conferences of YOUR choosing;
find microcap and emerging growth financial professionals that YOU
may be looking for - all here on StockNewsNow.com.
StockNewsNow.com
info@stocknewsnow.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/stocknewsnowcom-publishes-may-2016-update-snnlive-video-interview-with-provectus-biopharmaceuticals-inc-300269885.html
SOURCE StockNewsNow.com